See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356576_2023_Supernus_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001356576, Supernus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 734,151,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 819,482,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 148,875,000 |
| 4 | LiabilitiesCurrent | 687,958,000 |
| 5 | LiabilitiesNoncurrent | 44,690,000 |
| 6 | remainder_Liabilities | 83,656,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 643,846,270 |
| 9 | ResearchAndDevelopmentExpense | 77,491,754 |
| 10 | remainder_Expenses | 164,260,752 |
| 11 | remainder_Revenues | 759,329,257 |
| 12 | remainder_NetIncome | 5,018,379 |
| 13 | remainder_ComprehensiveNetIncome | -5,279,972 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,702,508,000 |
| 1 | Liabilities | 816,304,000 |
| 2 | Expenses | 885,598,776 |
| 3 | Revenues | 759,329,257 |
| 4 | StockholdersEquity | 886,204,000 |
| 5 | NetIncome | -121,251,140 |
| 6 | ComprehensiveNetIncome | -123,891,126 |
| 7 | BaseVar | 2,087,019,192 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.44 |
| 9 | EconomicCapitalRatio | 2.63 |
Edgar->Model Mapping
Feature Distribution
Change over Time
